Patent
DNA-based vaccination of fish
Heather L. Davis
- 04 Nov 1996
232
TL;DR: In this article, the authors proposed methods of immunization of aquaculture species by introducing DNA expression systems into the aquaulture species, which are useful for prophylactic vaccination or therapeutic immunization for finfish, shellfish, or other aquatic animals against infectious diseases.
read more
Abstract: The present invention relates to methods of immunization of aquaculture species by introducing DNA expression systems into the aquaculture species. Such DNA expression systems preferably include DNA sequences encoding polypeptides of pathogens of species of aquaculture. The present invention also relates to methods of administration of DNA expression systems into aquaculture. Such methods include injection, spray, and immersion techniques. The methods of this invention are useful for prophylactic vaccination or therapeutic immunization of fin-fish, shellfish, or other aquatic animals against infectious diseases.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Chimeric proteins for inducing immunity towards infection with s. aureus
Niels Iversen Møller,Andreas Holm Mattsson,Jens Vindahl Kringelum +2 more
- 24 Jul 2017
TL;DR: Chimeric polypeptides derived from S aureus proteins having SEQ ID NOs: 1-9 and 139-146 are useful as immunogens for providing protective immunity against S auresus infection as mentioned in this paper.
1
Patent
Methods and compositions involving let-7 miRNA molecules
David Brown,Lance P. Ford,Angie Cheng,Rich Jarvis,Mike Byrom,Dmitriy Ovcharenko,Eric Devroe,Kevin Kelnar,Frank J. Slack +8 more
- 09 Feb 2011
TL;DR: In this paper, the authors present methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules and identify miRNAs with specific cellular functions that arc relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNA and/or miRNA inhibitors are used in library screening assays.
1
Patent
Methods and compositions involving s-ship promoter regions
Larry R. Rohrschneider
- 18 Mar 2005
TL;DR: In this article, the s-ship promoter and developmental decision promoter compositions and methods of using the promoter are discussed. But they do not specify the methods of expressing a heterologous nucleic acid in a tissue-specific, developmental-specific or temporally controlled manner.
1
Patent
Angiopoietin-like protein 8 (angptl8)
Shuyuan Chen,Paul A. Grayburn +1 more
- 29 Mar 2017
TL;DR: In this paper, the disclosure concern methods and compositions for treatment of a cardiac-related medical condition, in particular, ANGPTL8 is provided to an individual in need thereof for the treatment or prevention of a cardiomyopathy, using ultrasound-targeted microbubble destruction.
1
Patent
Cardiac cell reprogramming with myocardin and ASCL1
Huanyu Zhou,Laura Lombardi +1 more
- 22 Sep 2020
TL;DR: In this paper, the authors provide methods for generating induced cardiomyocytes and/or inducing a Cardiomyocyte phenotype in cells in vivo or in vitro, such as by expression of ASCL1 or MYF6 and MYOCD.
1
References
Direct gene transfer into mouse muscle in vivo.
Jon A. Wolff,Robert W. Malone,Phillip Williams,Wang Chong,Gyula Acsadi,Agnes Jani,Philip L. Felgner +6 more
TL;DR: RNA and DNA expression vectors containing genes for chloramphenicol acetyltransferase, luciferase, and beta-galactosidase were separately injected into mouse skeletal muscle in vivo and expression was comparable to that obtained from fibroblasts transfected in vitro under optimal conditions.
4.4K
Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization
Yukio Sato,Mark Roman,H Tighe,Delphine J. Lee,Maripat Corr,Minh-Duc Nguyen,Gregg J. Silverman,Martin Lotz,Dennis A. Carson,Eyal Raz +9 more
TL;DR: Although ISS are necessary for gene vaccination, they down-regulate gene expression and thus may interfere with gene replacement therapy by inducing proinflammatory cytokines.
1.2K
Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression.
TL;DR: It is determined that much of the variability of expression is due to nonuniform distribution of substances injected into skeletal muscle in vivo, and a model to ameliorate this is developed.
519
In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment.
TL;DR: The particle bombardment method of gene transfer provides an alternative approach for analysis of in vivo promoter activity and transgene expression in mouse, rabbit, and rhesus monkey tissues and suggests that particle bombardment provides an effective system for studies of in vitro gene transfer and gene therapy.
361
Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle
TL;DR: The surprisingly high relative efficiency of pure plasmid DNA suggests that this method will provide a simple, safe and viable alternative for gene therapy involving muscle tissue.
339